Verily Powers Otsuka's Longitudinal Registry to Advance Mental Health Research
Otsuka and Verily have teamed up to launch a groundbreaking research initiative called "My Mental Health Journey."
Source: hitconsultant.net
Otsuka Pharmaceutical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Otsuka Pharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Otsuka Pharmaceutical Development Today - Breaking & Trending Today
Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyntm, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms
Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyntm (developed as CT-152), the first prescription digital therapeutic authorized for the...
Source: lelezard.com
Patient-Reported Disease Burden Predicts Odds of ADPKD Hospitalization
ADPKD progression is associated with symptoms, such as kidney pain, gross hematuria, and urinary tract infection, Disease-specific surveys capture the burden of autosomal dominant polycystic kidney disease (ADPKD) on patients and predict hospitalization.
Source: renalandurologynews.com
Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Feb 16, 2024--
Source: eagletribune.com
Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC); Otsuka Pharmaceutical, Co. Ltd. (Otsuka); and Visterra, Inc., an Otsuka group company announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat...
Source: pharmiweb.com